Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study

Harry L Hébert; Abirami Veluchamy; Georgios Baskozos; Francesca Fardo; Dimitri Van Ryckeghem; Ewan R Pearson; Lesley A Colvin; Geert Crombez; David L H Bennett; Weihua Meng; Colin N A Palmer; Blair H Smith

doi:10.1007/s00415-024-12721-6

Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study

Harry L Hébert, Abirami Veluchamy, Georgios Baskozos, Francesca Fardo, Dimitri Van Ryckeghem, Ewan R Pearson, Lesley A Colvin, Geert Crombez, David L H Bennett, Weihua Meng, Colin N A Palmer, Blair H Smith (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

6 Downloads (Pure)

Abstract

In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

Original language	English
Number of pages	2
Journal	Journal of Neurology
Early online date	13 Nov 2024
DOIs	https://doi.org/10.1007/s00415-024-12721-6
Publication status	Published - Dec 2024

ASJC Scopus subject areas

Neurology
Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00415-024-12721-6Licence: CC BY

Final Published VersionFinal published version, 417 KBLicence: CC BY

Cite this

Hébert, H. L., Veluchamy, A., Baskozos, G., Fardo, F., Van Ryckeghem, D., Pearson, E. R., Colvin, L. A., Crombez, G., Bennett, D. L. H., Meng, W., Palmer, C. N. A., & Smith, B. H. (2024). Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study. Journal of Neurology. https://doi.org/10.1007/s00415-024-12721-6

@article{3248bf15528f42db9df503fa5da160ac,

title = "Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study",

abstract = "In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).",

author = "H{\'e}bert, {Harry L} and Abirami Veluchamy and Georgios Baskozos and Francesca Fardo and {Van Ryckeghem}, Dimitri and Pearson, {Ewan R} and Colvin, {Lesley A} and Geert Crombez and Bennett, {David L H} and Weihua Meng and Palmer, {Colin N A} and Smith, {Blair H}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1007/s00415-024-12721-6",

language = "English",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Hébert, HL , Veluchamy, A, Baskozos, G, Fardo, F, Van Ryckeghem, D, Pearson, ER , Colvin, LA, Crombez, G, Bennett, DLH , Meng, W , Palmer, CNA & Smith, BH 2024, 'Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study', Journal of Neurology. https://doi.org/10.1007/s00415-024-12721-6

TY - JOUR

T1 - Correction

T2 - Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study

AU - Hébert, Harry L

AU - Veluchamy, Abirami

AU - Baskozos, Georgios

AU - Fardo, Francesca

AU - Van Ryckeghem, Dimitri

AU - Pearson, Ewan R

AU - Colvin, Lesley A

AU - Crombez, Geert

AU - Bennett, David L H

AU - Meng, Weihua

AU - Palmer, Colin N A

AU - Smith, Blair H

PY - 2024/12

Y1 - 2024/12

N2 - In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

AB - In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

UR - http://www.scopus.com/inward/record.url?scp=85208915957&partnerID=8YFLogxK

U2 - 10.1007/s00415-024-12721-6

DO - 10.1007/s00415-024-12721-6

M3 - Article

C2 - 39535542

SN - 0340-5354

JO - Journal of Neurology

JF - Journal of Neurology

ER -

Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study

Cite this